Cargando…
Clonal Non-Malignant Hematological Disorders: Unraveling Molecular Pathogenic Mechanisms to Develop Novel Targeted Therapeutics
Clonal non-malignant hematological disorders are a heterogeneous group of diseases that are particularly challenging for hematologists. Indeed, most obvious and frequent hematological diseases include a broad spectrum of malignancies, such as leukemias, lymphomas, myeloma, and other myeloproliferati...
Autores principales: | Risitano, Antonio M., Selleri, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Salerno
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000457/ https://www.ncbi.nlm.nih.gov/pubmed/24778992 |
Ejemplares similares
-
Cardiotoxicity of Novel Targeted Hematological Therapies
por: Giudice, Valentina, et al.
Publicado: (2020) -
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022) -
Infectious Agents and Bone Marrow Failure: A Causal or a Casual Connection?
por: Giudice, Valentina, et al.
Publicado: (2021) -
Centrosome Defects in Hematological Malignancies: Molecular Mechanisms and Therapeutic Insights
por: Hu, Mingzheng, et al.
Publicado: (2022) -
Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)